Diligence memo · auto-generated · as of July 3, 2026

Genesis Healthcare, Inc.

Genesis Healthcare, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Genesis Healthcare, Inc. operates in Other Health Care, based in KENNETT SQUARE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Genesis Healthcare, Inc. has raised $867M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Growth/Late (a round over $400M).

Largest single filing: $444M on 2015-02-02.

Most recent recorded round closed around 2015-02-02.

Valuation (modeled)modeled

Provath models Genesis Healthcare, Inc. at approximately $10.5B (range $3.3B–$18.9B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.93× the median modeled value of Growth/Late Other Health Care companies in 2013–2015 (5 peers) — value vs value, same stage and era. Within the normal band (93% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 11.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 100% of Other Health Care peers (5377 compared).

Modeled value ranks above 100% of those peers.

Closest niche peers: Hc Group Holdings I, Llc, Thermo Fisher Scientific Inc., Inventiv Health Inc, CareCore National Group, LLC.

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.